ViraxClear Signs Letter of Intent and Secures Purchase Order for Infrared Thermometers to North Africa May 22nd, 2020 - Vancouver, BC – Global Care Capital Corp. (CSE: HLTH, FRANKFURT: L6V1) (the “Company” or “Global Care”) a global investment company which engages in early stage investment opportunities in private and public companies, is pleased to announce that its portfolio company, ViraxClear, through its joint venture Shanghai Biotechnology Devices Ltd. (“SBD”) has on May 20th, 2020, finalized a Letter Of Intent (LOI) with Phyto Pharma Ltd (“Phyto”), for the supply of 5,000 FDA Registered and CE marked infrared thermometer units (“Thermometers”) for sale in North Africa, with a Purchase Order signed for the value of US$ 125,000 for the 5,000 units.
webfiles.thecse.com/sedar_filings/...175/2005220908142519.pdf